Everest Group Life Sciences Digital Services Specialists PEAK Matrix® Assessment 2024

Among its strengths in the most recent report, Axtria was recognized for offering specialized data analytics- and AI-driven commercial services for pharmaceuticals, medtech, and emerging biotechnology firms. The company was also cited for a wide range of partnerships, robust project execution, particularly in tight timelines, and broad training programs.

“The prevailing macroeconomic uncertainties have compelled life sciences enterprises to reassess their digital transformation approach, emphasizing investments that guarantee enhanced RoI rather than speculative, transformative initiatives. In this dynamic environment, businesses seek customized solutions tailored to their individual requirements. This is where specialized providers play a vital role, leveraging their domain expertise and specialized talent,” said Durga Ambati, Practice Director at Everest Group.

“Axtria's robust mix of domain-specific, data analytics/AI-driven commercial services are very well complemented by its investments in diverse, verticalized partnerships and talent initiatives. And, Axtria’s seamless project execution expertise and repertoire of life sciences specific thought leadership is highly valued by its clients, positioning it as a Leader in Life Sciences Digital Services Specialists PEAK Matrix® Assessment 2024.”